Time of performance of colonoscopy seems to be an independent predictor for adenoma detection. ADR was significantly higher in morning colonoscopies than in afternoon colonoscopies. The reasons and implications of this finding should be studied further.
AIMTo use a national database of United States hospitals to evaluate the incidence and costs of hospital admissions associated with gastroparesis.METHODSWe analyzed the National Inpatient Sample Database (NIS) for all patients in whom gastroparesis (ICD-9 code: 536.3) was the principal discharge diagnosis during the period, 1997-2013. The NIS is the largest publicly available all-payer inpatient care database in the United States. It contains data from approximately eight million hospital stays each year. The statistical significance of the difference in the number of hospital discharges, length of stay and hospital costs over the study period was determined by regression analysis.RESULTSIn 1997, there were 3978 admissions with a principal discharge diagnosis of gastroparesis as compared to 16460 in 2013 (P < 0.01). The mean length of stay for gastroparesis decreased by 20 % between 1997 and 2013 from 6.4 d to 5.1 d (P < 0.001). However, during this period the mean hospital charges increased significantly by 159 % from $13350 (after inflation adjustment) per patient in 1997 to $34585 per patient in 2013 (P < 0.001). The aggregate charges (i.e., “national bill”) for gastroparesis increased exponentially by 1026 % from $50456642 ± 4662620 in 1997 to $568417666 ± 22374060 in 2013 (P < 0.001). The percentage of national bill for gastroparesis discharges (national bill for gastroparesis/total national bill) has also increased over the last 16 years (0.0013% in 1997 vs 0.004% in 2013). During the study period, women had a higher frequency of gastroparesis discharges when compared to men (1.39/10000 vs 0.9/10000 in 1997 and 5.8/10000 vs 3/10000 in 2013). There was a 6-fold increase in the discharge diagnosis of gastroparesis amongst type 1 DM and 3.7-fold increase amongst type 2 DM patients over the study period (P < 0.001).CONCLUSIONThe number of inpatient admissions for gastroparesis and associated costs have increased significantly over the last 16 years. Inpatient costs associated with gastroparesis contribute significantly to the national healthcare bill. Further research on cost-effective evaluation and management of gastroparesis is required.
Unsedated esophagoscopy with a 4-mm esophagoscope was well tolerated and has a level of diagnostic accuracy comparable to that of conventional endoscopy. Factors associated with good tolerance of unsedated esophagoscopy were low anxiety levels, high body mass index, and use of the transnasal route. Unsedated endoscopy may be offered to a selected group of patients based on these criteria.
Recent studies have shown that nondividing primary cells, such as hepatocytes, can be efficiently transduced in vitro by human immunodeficiency virus-based lentivirus vectors. Other studies have reported that, under certain conditions, the liver can be repopulated with transplanted hepatocytes. In the present study, we combined these procedures to develop a model system for ex vivo gene therapy by repopulating rat livers with hepatocytes and hepatoblasts transduced with a lentivirus vector expressing a reporter gene, green fluorescent protein (GFP). Long-term GFP expression in vivo (up to 4 months) was achieved when the transgene was driven by the liver-specific albumin enhancer/promoter but was silenced when the cytomegalovirus (CMV) enhancer/promoter was used. Transplanted cells were massively amplified (ϳ10 cell doublings) under the influence of retrorsine/partial hepatectomy, and both repopulation and continued transgene expression in individual cells were documented by dual expression of a cell transplantation marker, dipeptidyl peptidase IV (DPPIV), and GFP. In this system, maintenance or expansion of the transplanted cells did not depend on expression of the transgene, establishing that positive selection is not required to maintain transgene expression following multiple divisions of transplanted, lentivirus-transduced hepatic cells. In conclusion, fetal hepatoblasts (liver stem/progenitor cells) can serve as efficient vehicles for ex vivo gene therapy and suggest that liver-based genetic disorders that do not shorten hepatocyte longevity or cause liver damage, such as phenylketonuria, hyperbilirubinemias, familial hypercholesterolemia, primary oxalosis, and factor IX deficiency, among others, might be amenable to treatment by this approach. (HEPATOLOGY 2003;37:994-1005.)
Objectives: Few studies have evaluated the long-term complications and
outcomes of esophageal atresia with or without tracheoesophageal fistula (EA/TEF)
beyond childhood. The aim of our study was to characterize the esophageal and
respiratory morbidity of EA/TEF through evaluation of clinical symptoms, diagnostic
testing and therapeutic intervention at a tertiary care center.Methods: Patients with congenital EA/TEF evaluated from 2011 to 2014
were included. Demographic characteristics, type and mode of repair of EA/TEF,
clinical symptoms, radiographic, endoscopic, bronchoscopic and medication use data
were obtained.Results: A total of 43 patients were identified. The median age of this
predominantly Caucasian population was 8 years (interquartile range: 3, 20). Twenty
(62.5%) had type C (EA with distal TEF) abnormality. Twenty-one (48.8%)
patients had heartburn, 19 (44.1%) had acid regurgitation, and 31
(72.1%) had dysphagia to solids. Barium swallow in 26 patients revealed
strictures in 17 (65.4%), dysmotility in 20 (76.9%) and recurrent
fistulas in four patients (15.4%). Thirty patients underwent upper endoscopy,
of which 21 (70.0%) had a stricture, and six (20.0%) had recurrent
fistula requiring surgical intervention. Eight (18.6%) patients underwent
fundoplication. Pulmonary evaluation showed cough and choking in 31 (72.1%)
patients and dyspnea and wheezing in 32 (53.4%) patients. Recurrent
respiratory infections were reported in 19 (44.2%).patients. Other findings
included tracheomalacia in 86.7% and restrictive lung disease in 54.5%
of patients.Conclusion: There is a high burden of residual esophageal and pulmonary
pathology in patients with EA/TEF. Ongoing follow-up is required to monitor both the
clinical symptoms and treatment responses.
In a prospective, multicenter cohort study, we found that patients with irregular Z line do not develop HGD or esophageal cancer within 5 years after index endoscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.